Employment Verification
for Akcea Therapeutics.
Fast, secure, and automated employment verification for Akcea Therapeutics employees.
$39.99 per verification
Pay only when it worksAbout Akcea Therapeutics
Akcea Therapeutics was a biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious and rare diseases. Founded in 2014, it operated as a subsidiary of Ionis Pharmaceuticals until 2017 when it became a public company. The company specialized in developing RNA-targeted therapeutics, particularly antisense oligonucleotides (ASOs). In 2018, Akcea received FDA approval for TEGSEDI (inotersen), a treatment for polyneuropathy caused by hereditary transthyretin-mediated amyloidosis (hATTR) in adults. The company also developed WAYLIVRA (volanesorsen), approved in the European Union for treating familial chylomicronemia syndrome (FCS). Akcea maintained strategic partnerships with Ionis Pharmaceuticals and Novartis, focusing on rare lipid disorders and cardiometabolic diseases. The company’s pipeline included several drug candidates targeting various rare diseases. In October 2020, Ionis Pharmaceuticals reacquired Akcea Therapeutics in a $500 million deal, making it a wholly-owned subsidiary once again. The acquisition aimed to streamline the development and commercialization of RNA-targeted therapeutics. Following the acquisition, Akcea’s operations were integrated into Ionis Pharmaceuticals’ structure.
The information on this page is not an endorsement of Truv’s services by Akcea Therapeutics and is meant to be purely informational.
Verify Akcea Therapeutics Employees
- Fast and automated verification: Most employment and income verifications are completed in under 24 hours.
- Secure and reliable: Truv is SOC2 TYPEII Compliant. Certified for Fannie Mae’s Day 1 Certainty® and Freddie Mac’s AIM®.
- Cost-effective pricing: Pay only for successful verifications and save up to 50% compared to competitors.
Category
BiotechnologyNumber of employees
200.0 – 500.0
Information sourced from public company data.
Akcea Therapeutics Employment Verification FAQs.
You can verify employment for Akcea Therapeutics employees through Truv, a secure and automated verification service. Truv provides quick and cost-effective employment verifications for Akcea Therapeutics and many other employers.
Yes, Truv offers both employment and income verification services for Akcea Therapeutics employees. This service is designed to be comprehensive, covering both employment status and income information.
Most verifications through Truv are completed in under 24 hours.
Yes, we emphasize security in our verification process. Truv provides secure and automated verifications to protect employee information.
Truv operates on a pay-per-success model, meaning you only pay for successful verifications. On average, users save about 50% compared to competitors’ services.
Yes, Truv provides verification services for various Biotechnology companies. Some examples mentioned include Dart NeuroScience, Hygiena and Prometheus Laboratories.
No, the information provided about Truv’s verification services is not an endorsement by the Akcea Therapeutics.
Not the employer you were looking for?
Also verified with Truv
About Akcea Therapeutics
Akcea Therapeutics was a biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious and rare diseases. Founded in 2014, it operated as a subsidiary of Ionis Pharmaceuticals until 2017 when it became a public company. The company specialized in developing RNA-targeted therapeutics, particularly antisense oligonucleotides (ASOs). In 2018, Akcea received FDA approval for TEGSEDI (inotersen), a treatment for polyneuropathy caused by hereditary transthyretin-mediated amyloidosis (hATTR) in adults. The company also developed WAYLIVRA (volanesorsen), approved in the European Union for treating familial chylomicronemia syndrome (FCS). Akcea maintained strategic partnerships with Ionis Pharmaceuticals and Novartis, focusing on rare lipid disorders and cardiometabolic diseases. The company’s pipeline included several drug candidates targeting various rare diseases. In October 2020, Ionis Pharmaceuticals reacquired Akcea Therapeutics in a $500 million deal, making it a wholly-owned subsidiary once again. The acquisition aimed to streamline the development and commercialization of RNA-targeted therapeutics. Following the acquisition, Akcea’s operations were integrated into Ionis Pharmaceuticals’ structure.
The information on this page is not an endorsement of Truv’s services by Akcea Therapeutics and is meant to be purely informational.
Verify Akcea Therapeutics Employees
Truv provides quick, secure and cost-effective employment and income verifications for thousands of verifiers. The process is simple and automated and most employees are verified in under 24 hours. You only pay for successful verification and can save on average 50% compared to competitors. Thousands of verifiers love Truv because it’s been never been easier and more streamlined to verify an employee. Learn more
Akcea Therapeutics Employment Verification FAQ.
You can verify employment for Akcea Therapeutics employees through Truv, a secure and automated verification service. Truv provides quick and cost-effective employment verifications for Akcea Therapeutics and many other employers.
Yes, Truv offers both employment and income verification services for Akcea Therapeutics employees. This service is designed to be comprehensive, covering both employment status and income information.
Most verifications through Truv are completed in under 24 hours.
Yes, we emphasizes security in our verification process. Truv provides secure and automated verifications to protect employee information.
Truv operates on a pay-per-success model, meaning you only pay for successful verifications. On average, users save about 50% compared to competitors’ services.
Yes, Truv provides verification services for various Biotechnology companies. Some examples mentioned include Dart NeuroScience, Hygiena and Prometheus Laboratories.
No, the information provided about Truv’s verification services is not an endorsement by the Akcea Therapeutics.
Yes, Truv provides an option to « Start a verification » directly from this website for Akcea Therapeutics employees and employees of many other organizations.